
SV Health’s $269M dementia fund; Schrödinger lays off 7% of staff
Plus, news about Beckley Psytech, Regenxbio, Blueprint Medicines, VantAI, NovelMed and Bayer:
💰 SV Health closes second dementia fund: The London-based biotech investment firm …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.